Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on June 1, 2025
Luis M. Gallardo Launches the Meta Pets Method, A Playful Path to Transformation for Therapists, Coaches, and Educators
EIN Presswire
·
June 1, 2025
A Card-Based System for Self-Inquiry, Healing, and Awakening in Education, Coaching, and Therapy. MIAMI, FL, UNITED STATES, June 1, 2025 /EINPresswire.com/ -- Author, hypnotherapist, and global well-being advocate Luis Miguel Gallardo announces the …
Impelsys Strengthens AI Transformation Strategy with AlgoShack Partnership
EIN Presswire
·
June 1, 2025
NEW YORK, NY, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Impelsys, a global leader in technology solutions, is pleased to announce its strategic partnership with AlgoShack, a company that offers algoQA—a unified platform for end-to-end test …
Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
GlobeNewswire
·
June 1, 2025
Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …
TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health
GlobeNewswire
·
June 1, 2025
LOS ANGELES, June 01, 2025 (GLOBE NEWSWIRE) -- As global temperatures continue to rise and daily comfort becomes a growing concern, TORRAS is making waves with its innovative Coolify series—a wearable air conditioner engineered to deliver rapid, personal …
Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML
GlobeNewswire
·
June 1, 2025
– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of adult …
Smile Scarsdale Family Dental Celebrates One Year of Smiles as Trusted Family Dentist in Scarsdale
EIN Presswire
·
June 1, 2025
SCARSDALE, NY, UNITED STATES, May 31, 2025 /EINPresswire.com/ -- Smile Scarsdale Family Dental is proud to celebrate its one-year anniversary of delivering exceptional family dental care to the Scarsdale community and surrounding areas. Since opening its …
Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025
GlobeNewswire
·
June 1, 2025
Median DOR of 21.7 months with 80% of responders achieving a deep response (≥80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3 months and 2-year OS of 46% in HPV-negative HNSCC Conference call and webcast today at …
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
GlobeNewswire
·
June 1, 2025
Data Highlights Transformative Promise of CAR T in Solid Tumors Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved a 31% …
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
June 1, 2025
- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were …
Planet TV Studios Presents New Frontiers Episode 'Highlighting Emerging Technologies' Featuring Athena Clinic & Dr. Daniel Murariu. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios
EIN Presswire
·
June 1, 2025
Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON,, FL, UNITED STATES, May 31, 2025 / …
Planet TV Studios Presents New Frontiers: Innovators Shaping Tomorrow. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios.
EIN Presswire
·
June 1, 2025
Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 / …
'New Frontiers' Presents 4 Companies Revolutionizing: Brian Cancer Therapies, Robotic Surgery, Sustainable Solutions & Data Centers. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios
EIN Presswire
·
June 1, 2025
Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 / …
"New Frontiers" Presents Featuring Athena Clinic, MonDak Portables, LLC, NeOnc Technologies Holdings, Inc. & Hollobus Technologies. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios.
EIN Presswire
·
June 1, 2025
Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 / …
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
GlobeNewswire
·
June 1, 2025
First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay to accelerate analysis and reduce costs, making large- …